Skip to content

All Courses

FDA First Annual Animal Drug User Fee Educational Conference – July 2024
FDA First Annual Animal Drug User Fee Educational Conference - July 2024

FDA First Annual Animal Drug User Fee Educational Conference – July 2024

Rx Drug Promotion and the Clear, Conspicuous, and Neutral Final Rule

Rx Drug Promotion and the Clear, Conspicuous, and Neutral Final Rule

OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2024 User Fees and Registration

OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2024 User Fees and Registration

OSIS Workshop: CDER Bioavailability/Bioequivalence Study Sites and Inspections of Good Laboratory Practice

OSIS Workshop: CDER Bioavailability/Bioequivalence Study Sites and Inspections of Good Laboratory Practice

FDA Regulatory Education for Industry (REdI) 2024 Conference – Plenary and Drugs Track
FDA CDER REdI Conference 2024

FDA Regulatory Education for Industry (REdI) 2024 Conference – Plenary and Drugs Track

FDA Regulatory Education for Industry (REdI) 2024 Conference – Devices Track
FDA REdI 2025 Conference - Devices Track

FDA Regulatory Education for Industry (REdI) 2024 Conference – Devices Track

FDA Regulatory Education for Industry (REdI) 2024 Conference – Biologics Track
REdI 2024 Conference -Biologics Track

FDA Regulatory Education for Industry (REdI) 2024 Conference – Biologics Track

Statistical Considerations for Premarketing Risk Assessment

Statistical Considerations for Premarketing Risk Assessment

Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval

Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval

Facilitating Generic Drug Product Development through Product-Specific Guidances

Facilitating Generic Drug Product Development through Product-Specific Guidances

1 2 3 4
Share: